Ratios Reveal: Breaking Down Lineage Cell Therapeutics Inc (LCTX)’s Financial Health

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Lineage Cell Therapeutics Inc (AMEX: LCTX) closed the day trading at $0.93 down -4.64% from the previous closing price of $0.97. In other words, the price has decreased by -$4.64 from its previous closing price. On the day, 1.38 million shares were traded. LCTX stock price reached its highest trading level at $0.98 during the session, while it also had its lowest trading level at $0.91.

Ratios:

For a better understanding of LCTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.71 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on November 02, 2022, initiated with a Outperform rating and assigned the stock a target price of $5.

On June 14, 2022, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.

On August 19, 2021, Noble Capital Markets started tracking the stock assigning a Outperform rating and target price of $8.Noble Capital Markets initiated its Outperform rating on August 19, 2021, with a $8 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 24 ’24 when Culley Brian M bought 10,000 shares for $1.05 per share. The transaction valued at 10,500 led to the insider holds 154,842 shares of the business.

BAILEY DON M bought 96,155 shares of LCTX for $100,001 on Feb 08 ’24. The Director now owns 158,801 shares after completing the transaction at $1.04 per share. On Feb 06 ’24, another insider, BROADWOOD PARTNERS, L.P., who serves as the Director of the company, bought 6,730,770 shares for $1.04 each. As a result, the insider paid 7,000,001 and bolstered with 41,666,255 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LCTX now has a Market Capitalization of 174662208 and an Enterprise Value of 132859288. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.83 while its Price-to-Book (P/B) ratio in mrq is 2.41. Its current Enterprise Value per Revenue stands at 16.601 whereas that against EBITDA is -6.473.

Stock Price History:

Over the past 52 weeks, LCTX has reached a high of $1.61, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -20.28%, while the 200-Day Moving Average is calculated to be -19.52%.

Shares Statistics:

Over the past 3-months, LCTX traded about 1.15M shares per day on average, while over the past 10 days, LCTX traded about 1376780 shares per day. A total of 188.82M shares are outstanding, with a floating share count of 188.00M. Insiders hold about 0.44% of the company’s shares, while institutions hold 50.35% stake in the company. Shares short for LCTX as of 1715731200 were 12369854 with a Short Ratio of 10.78, compared to 1713139200 on 10582768. Therefore, it implies a Short% of Shares Outstanding of 12369854 and a Short% of Float of 8.450000000000001.

Earnings Estimates

Its stock is currently analyzed by 4.0 different market analysts. On average, analysts expect EPS of -$0.04 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.05, while EPS last year was -$0.03. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.03 and low estimates of -$0.06.

Analysts are recommending an EPS of between -$0.02 and -$0.2 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is -$0.17, with 4.0 analysts recommending between -$0.08 and -$0.25.

Revenue Estimates

A total of 5 analysts have provided revenue estimates for LCTX’s current fiscal year. The highest revenue estimate was $35.85M, while the lowest revenue estimate was $1.4M, resulting in an average revenue estimate of $12.23M. In the same quarter a year ago, actual revenue was $8.95MBased on 4 analysts’ estimates, the company’s revenue will be $8.72M in the next fiscal year. The high estimate is $25.3M and the low estimate is $1.83M.

Most Popular